Intravenous Haloperidol Versus Ondansetron for Treatment of Established Post-operative Nausea and Vomiting
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
This study aims to prove that at a dose of 1 mg Haloperidol possesses a high success rate in
controlling established postoperative nausea and vomiting (PONV) in the first 24 hours
following administration similar to the standard of care ondansetron 4 mg.